Role of miR-10b-5p in the prognosis of breast cancer

Abstract

Breast cancer is the leading cause of cancer-related death in women worldwide. Aberrant expression levels of miR-10b-5p in breast cancer has been reported while the molecular mechanism of miR-10b-5p in tumorigenesis remains elusive. Therefore, this study was aimed to investigate the role of miR-10b-5p in breast cancer and the network of its target genes using bioinformatics analysis. In this study, the expression profiles and prognostic value of miR-10b-5p in breast cancer were analyzed from public databases. Association between miR-10b-5p and clinicopathological parameters were analyzed by non-parametric test. Moreover, the optimal target genes of miR-10b-5p were obtained and their expression patterns were examined using starBase and HPA database. Additionally, the role of these target genes in cancer development were explored via Cancer Hallmarks Analytics Tool (CHAT). The protein–protein interaction (PPI) networks were constructed to further investigate the interactive relationships among these genes. Furthermore, GO, KEGG pathway and Reactome pathway analyses were carried out to decipher functions of these target genes. Results demonstrated that miR-10b-5p was down-regulated in breast cancer and low expression of miR-10b-5p was significantly correlated to worse outcome. Five genes, BIRC5, E2F2, KIF2C, FOXM1, and MCM5, were considered as potential key target genes of miR-10b-5p. As expected, higher expression levels of these genes were observed in breast cancer tissues than in normal tissues. Moreover, analysis from CHAT revealed that these genes were mainly involved in sustaining proliferative signaling in cancer development. In addition, PPI networks analysis revealed strong interactions between target genes. GO, KEGG, and Reactome pathway analysis suggested that these target genes of miR-10b-5p in breast cancer were significantly involved in cell cycle. Predicted target genes were further validated by qRT-PCR analysis in human breast cancer cell line MDA-MB-231 transfected with miR-10b mimic or antisense inhibitors. Taken together, our data suggest that miR-10b-5p functions to impede breast carcinoma progression via regulation of its key target genes and hopefully serves as a potential diagnostic and prognostic marker for breast cancer.

LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p

“…The expression of miR-10b-5p has been reported to be dysregulated in breast cancer and associated with the prognosis [21] . In this step, the role of miR-10b-5p in TNBC was surveyed.…”

MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer

“…Mir-10b expression is deregulated in several types of cancer, however the reports regarding its expression profile in breast cancer are controversial (Iorio et al, 2005;Wang et al, 2019).…”

Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome

“…Similarly, elevated pre-miR-10b expression in prostate cancer has previously been associated with poor recurrence-free survival 19 . Elevated miR-10b-5p expression has also been associated with shorter survival in glioma 20 and non-small-cell lung cancer 21 , whereas miR-10b-5p has been reported as downregulated in breast and renal cancer 22,23 . In seeming contrast to our findings, two previous studies reported that miR-23a-3p was downregulated in prostate cancer vs. normal tissue 24,25 .…”